These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 448104)

  • 1. Involvement of proteases in the binding of EAC14OXY23b to complement receptor cells.
    Dierich MP; Landen B
    J Immunol; 1979 May; 122(5):1686-90. PubMed ID: 448104
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H; Okada N
    Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement receptors on cell membranes. I. Evidence for two complement receptors.
    Okada H; Nishioka K
    J Immunol; 1973 Nov; 111(5):1444-9. PubMed ID: 4795622
    [No Abstract]   [Full Text] [Related]  

  • 7. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
    Linscott WD
    J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
    [No Abstract]   [Full Text] [Related]  

  • 9. Restricted rosette formation with an EAC reagent prepared with serum of C3H/HeJ mice.
    van Dijk H; van Heuven-Nolsen D; Rademaker PM; Bloksma N; Willers JM
    Cell Immunol; 1980 May; 51(2):402-7. PubMed ID: 7371082
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation and partial characterization of sheep erythrocyte-antibody-complement intermediate.
    Rommel FA; Stolfi R
    Immunology; 1968 Oct; 15(4):469-79. PubMed ID: 5696260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A; Boumsell L; Borsos T; Good RA; Day NK
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity of C3- and C5-receptors on lymphoid cells.
    Landen B; Dierich MP
    J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mouse complement by different classes of mouse antibody.
    Klaus GG; Pepys MB; Kitajima K; Askonas BA
    Immunology; 1979 Dec; 38(4):687-95. PubMed ID: 521057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
    Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anti-macrophage sera on the in vivo synthesis of guinea pig complement components.
    Füst G; Surján M
    Boll Ist Sieroter Milan; 1971; 50(6):488-94. PubMed ID: 5164108
    [No Abstract]   [Full Text] [Related]  

  • 20. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.